Orland Park - University of Chicago Center for Advanced Care — Orland Park, Illinois

Orland Park - University of Chicago Center for Advanced Care is a clinical research site located in Orland Park, Illinois, United States 60462.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Orland Park - University of Chicago Center for Advanced Care has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Triple-negative Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Orland Park - University of Chicago Center for Advanced Care?

Orland Park - University of Chicago Center for Advanced Care has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Orland Park - University of Chicago Center for Advanced Care conducted?

Orland Park - University of Chicago Center for Advanced Care has 2 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Triple-negative Breast Cancer.

Is Orland Park - University of Chicago Center for Advanced Care accredited by Crixeo Health?

Orland Park - University of Chicago Center for Advanced Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Orland Park - University of Chicago Center for Advanced Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.